ISIS-SGLT2Rx

· Ionis Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ISIS-SGLT2Rx, covering 2012-02-03 to 2012-02-03. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Activity Study of Multiple Doses of ISIS-SGLT2Rx in Healthy Volunteers [Phase 1]